A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients

Larynx preservation (LP) is recommended for up to low-volume T4 laryngeal cancer as an evidence-based treatment option that does not compromise survival. However, a reevaluation of the current literature raises questions regarding whether there is indeed reliable evidence to support larynx preservat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dyckhoff, Gerhard (VerfasserIn) , Plinkert, Peter K. (VerfasserIn) , Ramroth, Heribert (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 September 2017
In: BMC cancer
Year: 2017, Jahrgang: 17
ISSN:1471-2407
DOI:10.1186/s12885-017-3608-7
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12885-017-3608-7
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-017-3608-7
Volltext
Verfasserangaben:Gerhard Dyckhoff, Peter K. Plinkert and Heribert Ramroth
Beschreibung
Zusammenfassung:Larynx preservation (LP) is recommended for up to low-volume T4 laryngeal cancer as an evidence-based treatment option that does not compromise survival. However, a reevaluation of the current literature raises questions regarding whether there is indeed reliable evidence to support larynx preservation for T4 tumor patients.
Beschreibung:Gesehen am 21.09.2017
Beschreibung:Online Resource
ISSN:1471-2407
DOI:10.1186/s12885-017-3608-7